Showing results (1401-1410 of 3,591) with videos related to
Sort By:
Pageof 360
Journal of Viral Hepatitis|July 3, 2021
The effects of hepatitis B virus infection on natural and IVF pregnancy: A meta-analysis studyMarziye Farsimadan, Seyed Mohammad Riahi, Huda Muhaddien Muhammad, et al.Journal of Viral Hepatitis|July 16, 2021
The impact of direct-acting antivirals on hepatitis C viraemia among people who inject drugs in England; real-world data 2011-2018Megan Bardsley, Ellen Heinsbroek, Ross Harris, et al.Journal of Viral Hepatitis|December 11, 2020
High rates of sustained virological response despite premature discontinuation of directly acting antivirals in HCV-infected patients treated in a real-life settingMassimiliano Fabbiani, Andrea Lombardi, Marta Colaneri, et al.Journal of Viral Hepatitis|July 27, 2021
Effectiveness of direct acting antiviral agents for hepatitis C virus related recurrent hepatocellular carcinoma patients who had multiple courses of recurrenceTakamasa Ohki, Koki Sato, Mayuko Kondo, et al.Journal of Viral Hepatitis|July 28, 2021
Neuropsychological effects of direct-acting antiviral treatment for Hepatitis C virus subjects: A systematic reviewCassio Santos-Lima, Breno Souza-Marques, Flávia Vieira, et al.Journal of Viral Hepatitis|March 16, 2013
Sequential therapy with entecavir and PEG-INF in patients affected by chronic hepatitis B and high levels of HBV-DNA with non-D genotypesL Boglione, A D'Avolio, G Cariti, et al.Journal of Viral Hepatitis|March 16, 2013
Lack of clinical and histological progression of chronic hepatitis C in individuals with true persistently normal ALT: the result of a 17-year follow-upG Nunnari, M R Pinzone, B CacopardoJournal of Viral Hepatitis|March 16, 2013
Mechanism of the dependence of hepatitis B virus genotype G on co-infection with other genotypes for viral replicationT Sakamoto, Y Tanaka, T Watanabe, et al.Journal of Viral Hepatitis|March 16, 2013
Screening for autoantibodies in chronic hepatitis C patients has no effect on treatment initiation or outcomeS Mauss, F Berger, A Schober, et al.Journal of Viral Hepatitis|May 8, 2013
Analysis of genotype 2 and 3 hepatitis C virus variants in patients treated with telaprevir demonstrates a consistent resistance profile across genotypesS De Meyer, A Ghys, G R Foster, et al.Pageof 360